baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Plexus Corp/ US7291321005 /

2024-06-05 10:00:00 PM	Chg. +0.0300	Volume	Bid10:09:50 AM	Ask10:09:50 AM	Market Capitalization	Dividend Y.	P/E Ratio
107.8000USD	+0.03%	79,768 Turnover: 4.7 mill.	43.3300Bid Size: 100	171.4000Ask Size: 100	2.95 bill.USD	-	21.39

GlobeNewswire 05-30 Pacira BioSciences to Participate in Fireside Chat at the 2024 Jefferies Global Healthcare Conferenc...

GlobeNewswire 05-21 Plexus to Present at the 2024 Stifel Cross Sector Insight Conference

GlobeNewswire 05-10 Pacira BioSciences, Inc. Announces Pricing of $250.0 Million Aggregate Principal Amount of 2.125% Co...

GlobeNewswire 05-08 Pacira BioSciences, Inc. Announces Proposed Offering of $250.0 Million Aggregate Principal Amount of...

GlobeNewswire 05-07 Pacira BioSciences Reports First Quarter 2024 Financial Results and Announces $150 Million Share Rep...

GlobeNewswire 05-07 Simbe Announces Partnership with Plexus Corp. to Scale Manufacturing and Meet Global Retail Demand

GlobeNewswire 05-07 Pacira BioSciences to Participate in Fireside Chat at the 2024 RBC Capital Markets Global Healthcare...

GlobeNewswire 04-24 Plexus Announces Fiscal Second Quarter Financial Results

GlobeNewswire 04-16 2024 DTA Summit Agenda is LIVE!!

GlobeNewswire 04-10 Plexus Sets Fiscal Second Quarter 2024 Earnings Release Date

GlobeNewswire 04-02 Pacira BioSciences to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Con...

GlobeNewswire 03-13 Pacira BioSciences Announces PCRX-201 Granted Regenerative Medicine Advance Therapy (RMAT) Designati...

GlobeNewswire 03-06 Pacira BioSciences to Participate in Fireside Chat at the Barclays 26th Annual Global Healthcare Con...

GlobeNewswire 02-29 Wisconsin's Drive for $75M Towards Personalized Medicine Innovation

GlobeNewswire 02-29 Pacira BioSciences Reports Fourth Quarter and Full-Year 2023 Financial Results

GlobeNewswire 02-20 Plexus to Present at the Raymond James 45th Annual Institutional Investors Conference

GlobeNewswire 02-15 Pacira Announces Publication of Pivotal Study of EXPAREL as a Sciatic Nerve Block in the Popliteal F...

GlobeNewswire 02-07 Pacira BioSciences Awarded Brand Pharmaceuticals Agreement With Premier, Inc.

GlobeNewswire 01-24 Plexus Announces Fiscal First Quarter Financial Results

GlobeNewswire 01-16 Plexus Announces Preliminary Fiscal First Quarter 2024 Results and Additional Share Repurchase Progr...

GlobeNewswire 01-04 Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2023 Revenues

GlobeNewswire 01-03 Pacira BioSciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire 2023-12-27 Plexus Provides Update on Unverified List Removal

GlobeNewswire 2023-12-21 Pacira Appoints Frank D. Lee as Chief Executive Officer

GlobeNewswire 2023-12-20 Plexus Provides Update on Unverified List Designation

Plexus Corp/ US7291321005 /

If you wish to receive reply to your feedback, please provide your email address.